Login / Signup

ECG and Biomarker Profile in Patients with Acute Heart Failure: A Pilot Study.

Adriana ChetranAlexandru-Dan CostacheCarmen-Iulia CiongradiStefania Teodora DucaOvidiu MituVictorita SorodocCorina Maria CiangaCristina TuchilusIvona MituRaluca Daria MiteaMinerva Codruţa BădescuIrina DemșaBogdan HuzumȘtefana-Maria MoisăCristian Sorin PrepeliucMihai RocaIrina Iuliana Costache
Published in: Diagnostics (Basel, Switzerland) (2022)
The statistical relationships found between cardiac biomarkers and ECG patterns support the added value of ECG in the diagnosis of AHF. We emphasize the importance of proper ECG analysis of more subtle parameters that can easily be missed. As a non-invasive technique, ECG can be used in the outpatient setting as a warning signal, announcing the acute decompensation of HF. In addition, the information provided by the ECG complements the biomarker results, supporting the diagnosis of AHF in cases of dyspnea of uncertain etiology. Further studies are needed to confirm long-term prognosis in a multi-marker approach.
Keyphrases
  • heart rate variability
  • heart rate
  • acute heart failure
  • heart failure
  • liver failure
  • drug induced
  • palliative care
  • hepatitis b virus
  • social media
  • extracorporeal membrane oxygenation
  • advanced cancer